Delivery Order SPE2DX15D8003-SPE2DX24F7D8D
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,948.24, is for the delivery of 4,564,623,874 units of the prescription medication Vyvanse 20 mg capsules. The contract has a performance period ending on May 16, 2024 and was awarded on May 15, 2024 without any set-aside designation. Dakota Drug, Inc. is an experienced prime...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is valued at $2,927.72 and covers the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed Forces. The contract has an ultimate completion date of May 30, 2024 and...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business, for the supply of 4,565,030 units of the prescription medication Vyvanse 20 mg capsules. The contract, valued at $7,180.98, has an ultimate completion date of June 28, 2024. Dakota Drug, Inc. has over two decades of experience providing pharmaceutical products and medical supplies to the U.S....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $3,583.12, is for the delivery of 100 capsules of the pharmaceutical drug Vyvanse 30 mg. This award is not associated with a set-aside program. Dakota Drug, Inc. has an extensive contract history with the DLA Troop Support Medical,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,073.16 firm fixed-price contract is for the delivery of 100 units of the prescription medication Vyvanse 40 mg capsules. This award falls under Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
- This firm fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,289.44, is for the delivery of Vyvanse 50 mg capsules. The award does not have a set-aside designation. As a prime contractor to the Department of Defense, Dakota Drug, Inc. has over two decades of experience providing a wide range of pharmaceutical products, medical supplies, and healthcare...
- This $2,015.44 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through March 13, 2024. This delivery order was issued under a larger DLA contract vehicle and does not utilize any set-aside designations....
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide VYVANSE 60 MG CAPSULE 100S. This award, valued at $3,341.50, has a completion date of January 18, 2024. Dakota Drug, Inc. serves as a prime contractor supplying pharmaceuticals, medical equipment, and related consumables to support military treatment facilities under the agency's blanket purchase agreement and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,201.92, is for the delivery of 100 units of the prescription medication Vyvanse 30 mg capsules. It is a firm fixed-price delivery order contract with a completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001 and valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 100 units of the prescription medication Vyvanse 50 mg capsules, with a total ceiling value of $1,328.62 and a performance period through July 24, 2024. The contract is not designated as a set-aside and is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
- SPE2DX15D8003Indefinite Delivery Contract
- SPE2DX15D8003-SPE2DX24F7D8DDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The award, valued at $1,341.22, is for the provision of 10 mg Vyvanse capsules (100 count) to support medical supply chain operations for the U.S. Armed Forces. The contract has a completion date of May 15, 2024 and was awarded on May 14, 2024 without the use of a set-aside designation. Dakota Drug, Inc. has over two decades of experience delivering a wide range of pharmaceutical products, medical supplies, and healthcare equipment to the DLA Troop Support Medical, which is responsible for providing comprehensive medical support to the U.S. military.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/14/24 |